← SynDRA

BALAPIRAVIR

SynDRA canonical compound SYN0019823 — structure-anchored drug synonym record

All known targets

• HCV NS5B
• MycB rpoA
• MycB rpoB
• MycB rpoC
• MycB rpoZ

Mechanisms of action (all sources)

• RNA polymerase inhibitor
• HCV NS5B INHIBITOR
• HCV inhibitor
• MycB rpoA; MycB rpoB; MycB rpoC; MycB rpoZ INHIBITOR

Bioactivity evidence (ChEMBL activities table — not curator-asserted)

• HDAC6
• POLRMT

Cross-references

• PubChem CID: 11691726
• ChEMBL: CHEMBL550936
• DrugBank: DB05060
• KEGG: D09582
• Wikipedia: Balapiravir
• TTD: D01FUL
• LINCS BRD: BRD-K47976015

Synonyms

• R-1626
• R1626
• RO-4588161
• RO4588161
• Balapiravir hydrochloride
• HCV NS5B polymerase inhibitor, Roche
• RO4588161-001
• RNA polymerase inhibitor (HCV infection), Roche
• RNA polymerase inhibitor (hepatitis C infection), Roche
• R-1479 prodrug (HCV infection), Roche
• 4'-C-Azidocytidine 2',3',5'-tris(2-methylpropanoate)
• Ro 4588161
• (2R,3S,4R,5R)-5-(4-amino-2-oxopyrimidin-1(2H)-yl)-2-azido-2-((isobutyryloxy)methyl)tetrahydrofuran-3,4-diyl bis(2-methylpropanoate)
• Balapiravir [USAN]
• VOT0LP7I9K
• BALAPIRAVIR [INN]
• BALAPIRAVIR [WHO-DD]
• Cytidine, 4'-C-azido-, 2',3',5'-tris(2-methylpropanoate)
• CHEMBL550936
• SCHEMBL13592072
• DTXSID40219098
• ZINC35328439
• CS-0369
• DB12283
• NCGC00378751-01
• HY-10443
• Q17070900
• [(2R,3S,4R,5R)-5-(4-amino-2-oxopyrimidin-1-yl)-2-azido-3,4-bis(2-methylpropanoyloxy)oxolan-2-yl]methyl 2-methylpropanoate
• 4-AMINO-1-(4-C-AZIDO-2',3',5'-TRI-O-(2-METHYLPROPANOYL)-.BETA.-D-RIBOFURANOSYL)PYRIMIDIN- 2(1H)-ONE
• R 1626
• balapiravirum
• RefChem:916692
• DTXCID60141589
• C21H30N6O8
• Ro 4588161;R1626
• orb1707596
• EX-A12382
• MFCD18251433